Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Thomas Tüting

Director

University Hospital Magdeburg

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Immunology Immunology professors in Germany

Articles (19)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (13)

Selma Ugurel

GERMANY

View details

Semir Beyaz

Principal Investigator

Cold Spring Harbor Laboratory

UNITED STATES

View details

Lenka Besse

Masaryk University

CZECH REPUBLIC

View details

Denny Schanze

Institute of Human Genetics

GERMANY

View details

Evelyn Gaffal

University Hospital Magdeburg

GERMANY

View details

Olaf Prante

friedrich-alexander-universität erlangen-nürnberg (fau)

GERMANY

View details

Oliver Schmitz

Full Professor and Chair

Universität Duisburg-Essen

GERMANY

View details

Philipp Tripal

Staff Scientist

Friedrich-Alexander Universität Erlangen-Nürnberg

GERMANY

View details

Sven W. Meckelmann

Universität Duisburg-Essen

GERMANY

View details

Michael Stürzl

Professor

Friedrich-Alexander Universität Erlangen-Nürnberg

GERMANY

View details

Andreas Dominik Braun

Professor for Digital and Molecular Dermatopathology

University of Lübeck

GERMANY

View details

Alexander Lercher

Junior Group Leader

Heidelberg University

GERMANY

View details

Robin PD Dr. Reschke

Research Group Leader

Heidelberg University

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Thomas Tüting

Research Interests

Explore related searches

Articles (19)

Outcome of systemic therapy in patients with advanced rare skin cancers: A retrospective multicenter DeCOG study of 209 patients

Subcutaneous pedicle subunit flap for upper lip reconstruction

A lipid made by tumour cells reprograms immune cells

Loss of Pip4k2c confers liver-metastatic organotropism through insulin-dependent PI3K-AKT pathway activation

Transactivation of Met signaling by oncogenic Gnaq drives the evolution of melanoma in Hgf-Cdk4 mice

Advanced Deep Learning for Skin Histoglyphics at Cellular Level

Comprehensive analysis of body composition features in melanoma patients treated with tyrosine kinase inhibitors

Effectiveness, safety and utilization of cobimetinib and vemurafenib in patients with BRAF V600 mutant melanoma with and without cerebral metastasis under real-world conditions in Germany: The non-interventional study coveNIS

Low skeletal muscle mass predicts melanoma-specific survival in melanoma patients treated with adjuvant immune checkpoint blockade

Sarcopenia and immune-related toxicity in patients with malignant melanoma undergoing immune checkpoint inhibition,Die Bedeutung von Sarkopenie für die immunvermittelte Toxizität bei Patienten mit malignem Melanom unter einer Immuncheckpoint-Inhibition

TIL the end: Tracking T cell clonotype dynamics during adoptive cell therapy

Umfassende Analyse des Einflusses der Body Composition auf die Wirksamkeit und das Nebenwirkungsprofil einer Systemtherapie mit Tyrosinkinaseinhibitoren bei Melanompatienten

N-glycosylation Regulates Intrinsic IFN-γ Resistance in Colorectal Cancer: Implications for Immunotherapy

A replicating LCMV-based vaccine for the treatment of solid tumors.

Acantholytic squamous cell carcinoma in a patient with junctional epidermolysis bullosa

Akantholytisches Plattenepithelkarzinom bei einer Patientin mit junktionaler Epidermolysis bullosa

CD4<sup>+</sup> T cell-induced inflammatory cell death controls immune-evasive tumours

Subcutaneous Fat Abundance and Density Are Associated with an Enhanced Response to Immunotherapy in Metastatic Melanoma: A Retrospective Cohort Study

Visual Analytics to Support Treatment Decisions in Late-Stage Melanoma Patients

Collaborators (13)

Selma Ugurel

Semir Beyaz

Lenka Besse

Denny Schanze

Evelyn Gaffal

Olaf Prante

Oliver Schmitz

Philipp Tripal

Sven W. Meckelmann

Michael Stürzl

Andreas Dominik Braun

Alexander Lercher

Robin PD Dr. Reschke

Make your next move.